Is it safe to combine an SSRI (Selective Serotonin Reuptake Inhibitor) with mirtazapine (45mg) and amitriptyline?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
DS

Dainyal Siddiqui, MD

Internal Medicine

MJ

Manuel Jimenez, MD

Cardiology

FP

Franz Pierre-Louis, MD

Infectious Disease

Article Review Status
Submitted
Under Review
Approved

Last updated: June 2, 2025 • View editorial policy

From the Guidelines

Combining an SSRI with mirtazapine (45mg) and amitriptyline is not recommended due to significant safety concerns, including the risk of serotonin syndrome, excessive sedation, and QT interval prolongation. This combination poses a high risk of adverse effects, particularly serotonin syndrome, a potentially life-threatening condition caused by excessive serotonin levels in the brain 1. All three medications affect serotonin: SSRIs block its reuptake, mirtazapine affects serotonin receptors, and amitriptyline has both serotonergic and noradrenergic effects.

Key Considerations

  • The risk of serotonin syndrome is a major concern with this combination, as it can be life-threatening if not recognized and treated promptly.
  • Both amitriptyline and mirtazapine can cause sedation, potentially leading to excessive drowsiness when combined with an SSRI.
  • All three medications may contribute to QT interval prolongation, increasing the risk of dangerous heart rhythm disturbances.
  • The therapeutic ranges of these medications, as outlined in the guidelines, should be carefully considered to avoid toxicity, with recommended ranges including 80-200 ng/mL for amitriptyline plus nortriptyline, 40-80 ng/mL for mirtazapine, and varying ranges for different SSRIs 1.

Recommendations for Safe Management

  • If you're currently taking this combination or considering it, consult with your healthcare provider immediately to discuss safer alternatives.
  • Only a qualified healthcare provider who knows your complete medical history can determine if any combination of these medications might be appropriate in your specific case, and if so, what monitoring would be required to ensure safety.
  • Close monitoring for signs of serotonin syndrome, sedation, and cardiac effects is crucial if this combination is deemed necessary by a healthcare provider.

From the FDA Drug Label

Serotonergic antidepressants, including mirtazapine tablets, can precipitate serotonin syndrome, a potentially life-threatening condition. The risk is increased with concomitant use of other serotonergic drugs (including triptans, tricyclic antidepressants, fentanyl, lithium, tramadol, tryptophan, buspirone, amphetamines, and St. John’s Wort) and with drugs that impair metabolism of serotonin, i. e., MAOIs [see Contraindications (4), Drug Interactions (7)]. Mirtazapine tablets and other medicines may affect each other causing possible serious side effects Mirtazapine tablets may affect the way other medicines work and other medicines may affect the way mirtazapine tablets work. Especially tell your healthcare provider if you take: • MAOIs • medicines to treat migraine headaches known as triptans • tricyclic antidepressants • fentanyl • lithium • tramadol • tryptophan • buspirone • amphetamines • benzodiazepines • St John’s Wort • medicines used to treat mood, anxiety, psychotic or thought disorders, including selective serotonin reuptake inhibitors (SSRIs) and serotonin norepinephrine reuptake inhibitors (SNRIs) • medicines that may affect your heart rhythm (such as certain antibiotics and some antipsychotics)

Combining an SSRI with mirtazapine (45mg) and amitriptyline may increase the risk of serotonin syndrome, a potentially life-threatening condition.

  • Key points to consider: + The concomitant use of multiple serotonergic drugs, including SSRIs, tricyclic antidepressants, and mirtazapine, increases the risk of serotonin syndrome. + Patients should be closely monitored for signs and symptoms of serotonin syndrome, such as mental status changes, autonomic instability, neuromuscular symptoms, seizures, and gastrointestinal symptoms. + The combination of these medications should be approached with caution, and patients should be informed of the increased risk of serotonin syndrome. + It is essential to weigh the potential benefits of this combination against the potential risks and to consider alternative treatment options. + If this combination is deemed necessary, patients should be closely monitored, and the healthcare provider should be prepared to intervene promptly if signs or symptoms of serotonin syndrome occur 2, 3.

From the Research

Combination of SSRI, Mirtazapine, and Amitriptyline

  • The combination of an SSRI with mirtazapine and amitriptyline is a complex regimen that requires careful consideration of potential interactions and side effects.
  • There is evidence to suggest that combining serotonergic agents, such as SSRIs and mirtazapine, can increase the risk of serotonin syndrome, a potentially life-threatening condition 4, 5.
  • A study published in 2004 reported a case of serotonin syndrome induced by the combination of bupropion and an SSRI, highlighting the potential risks of combining serotonergic agents 6.
  • Another study published in 2018 investigated the combination of mirtazapine with SSRIs or SNRIs for treatment-resistant depression, but found no convincing evidence of a clinically important benefit 7.
  • The addition of amitriptyline, a tricyclic antidepressant, to this combination may further increase the risk of serotonin syndrome and other adverse effects.
  • It is essential to carefully weigh the potential benefits and risks of this combination and to monitor patients closely for signs of serotonin syndrome and other adverse effects.

Safety Considerations

  • The safety of combining an SSRI with mirtazapine and amitriptyline has not been extensively studied, and the available evidence suggests that this combination may be associated with an increased risk of adverse effects.
  • Patients taking this combination should be closely monitored for signs of serotonin syndrome, including agitation, confusion, rapid heart rate, and changes in blood pressure.
  • The dosage of each medication should be carefully considered, and patients should be started on low doses with gradual titration as needed and tolerated.
  • Alternative treatment options should be considered for patients who are at high risk of adverse effects or who have a history of serotonin syndrome.

Clinical Implications

  • Clinicians should exercise caution when prescribing this combination and should carefully consider the potential risks and benefits for each patient.
  • Patients should be educated about the potential risks of serotonin syndrome and should be instructed to seek medical attention immediately if they experience any symptoms.
  • Further research is needed to fully understand the safety and efficacy of this combination and to identify potential strategies for minimizing the risk of adverse effects.

References

5
Research

Severe serotonin syndrome induced by mirtazapine monotherapy.

The Annals of pharmacotherapy, 2002

7
Research

Combining mirtazapine with SSRIs or SNRIs for treatment-resistant depression: the MIR RCT.

Health technology assessment (Winchester, England), 2018

Related Questions

What is Mitral Valve (MV) syndrome?
What antidepressant can be given with Quetiapine (Seroquel)?
What are the guidelines for combining mirtazapine with escitalopram (Lexapro) in elderly patients?
Is Mirtazapine (Remeron) safe to take with Fluoxetine (Prozac)?
What is Post-Selective Serotonin Reuptake Inhibitor (SSRI) syndrome?
What is the recommended treatment for a 78-year-old patient with a possible urinary tract infection (UTI) and urinalysis results showing bacteriuria and leukocyturia?
How to manage metabolic alkalosis with a high pH, low CO2 (carbon dioxide), and elevated bicarbonate level?
What is the initial approach to managing patients with thrombocytosis (elevated platelet count)?
What is the recommended protocol for switching a patient from amitriptyline (tricyclic antidepressant) to fluoxetine (selective serotonin reuptake inhibitor, SSRI)?
What is the recommended treatment for patients with anti-cardiolipin antibodies and a history of thrombosis?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Ask a new Question. Chat with the Guidelines